Quadria Capital invests $100m in IPO-bound Aragen Life Sciences

Quadria Capital invests $100m in IPO-bound Aragen Life Sciences

Biotech lab. Photo by Pixabay

Edited by: Joymitra Rai

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter